AJP - GI AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (February 5, 2009). doi:10.1152/ajpgi.90627.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/4/G704    most recent
90627.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Fallon, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Fallon, M. B.
Submitted on October 30, 2008
Revised on December 17, 2008
Accepted on December 18, 2008

Attenuation of Experimental Hepatopulmonary Syndrome in Endothelin B Receptor-deficient Rats

Junlan Zhang1*, Yiqun Ling1, Liping Tang1, Bao Luo1, David M. Pollock2, and Michael B. Fallon3

1 University of Alabama at Birmingham
2 Medical College of Georgia
3 U of Alabama Birmingham

* To whom correspondence should be addressed. E-mail: jlzhang{at}uab.edu.

Experimental hepatopulmonary syndrome (HPS) after common bile duct ligation (CBDL) in rat is accompanied by increased lung vascular endothelial endothelin B (ETB) receptor expression and increased circulating levels of endothelin-1 (ET-1). The onset of HPS is hypothesized to be triggered by ET-1/ETB receptor activation of endothelial nitric oxide synthase (eNOS) derived NO production in the pulmonary endothelium. However, whether functional pulmonary vascular ETB receptors are required for the development of experimental HPS is not defined. We evaluated the effects of vascular ETB receptor deficiency on the development of experimental HPS. The molecular and physiologic alterations of HPS were compared in 2 wk CBDL wild type and ETB receptor-deficient (transgenic sl/sl) rats. Relative to wild type rats, basal hepatic and plasma ET-1 levels were elevated in sl/sl controls, although unlike wild type animals, circulating ET-1 levels did not increase further after CBDL in sl/sl animals. In contrast to wild type animals, ETB receptor deficient rats did not develop increased Akt and eNOS expression and activation and did not develop gas exchange abnormalities of HPS after CBDL. There was a similar degree of pulmonary intravascular monocyte accumulation in both 2 wk CBDL sl/sl and wild type animals. In conclusion, ETB receptor deficiency inhibits lung Akt/eNOS activation and prevents the onset of experimental HPS after CBDL. This effect is independent of inhibition of pulmonary intravascular monocyte accumulation. These results demonstrate that ET-1/ETB receptor signaling plays a key role in the initiation of experimental HPS.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.